Stock VRPX VIRPAX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Virpax Pharmaceuticals, Inc.

Equities

VRPX

US9282512063

Market Closed - Nasdaq
Other stock markets
 12:49:44 2024-07-03 pm EDT 		5-day change 1st Jan Change
0.531 USD +0.17% Intraday chart for Virpax Pharmaceuticals, Inc. +6.69% -83.41%
May. 22 Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy MT
May. 15 Virpax Prices Public Offering of Shares, Warrants; Shares Tumble MT

Evolution of the average Target Price on Virpax Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d93dee7c27.6fTIw3ykG2Z2IALULV1cI3Di4LliMhIMD_onjYTEJ0c.naKvqCPLYTAZZTezeD82Fjevqf0yc2I6bZUR2OiQUjWvu4PuLf5cUTpSZQ~94ca573fb702f73c998351fc6c0e9f32

Analyst Recommendations on Virpax Pharmaceuticals, Inc.

Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy MT
Maxim Group Initiates Coverage on Virpax Pharmaceuticals With Buy Rating, $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.531 USD
Average target price
20 USD
Spread / Average Target
+3,666.48%
High Price Target
20 USD
Spread / Highest target
+3,666.48%
Low Price Target
20 USD
Spread / Lowest Target
+3,666.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Virpax Pharmaceuticals, Inc.

Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VRPX Stock
  4. Consensus Virpax Pharmaceuticals, Inc.